382 related articles for article (PubMed ID: 29196183)
1. NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.
Cadinu D; Grayson B; Podda G; Harte MK; Doostdar N; Neill JC
Neuropharmacology; 2018 Nov; 142():41-62. PubMed ID: 29196183
[TBL] [Abstract][Full Text] [Related]
2. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Neill JC; Barnes S; Cook S; Grayson B; Idris NF; McLean SL; Snigdha S; Rajagopal L; Harte MK
Pharmacol Ther; 2010 Dec; 128(3):419-32. PubMed ID: 20705091
[TBL] [Abstract][Full Text] [Related]
3. Acute NMDA receptor antagonism impairs working memory performance but not attention in rats-Implications for the NMDAr hypofunction theory of schizophrenia.
Lee J; van den Buuse M; Nithianantharajah J; Jones NC
Behav Neurosci; 2020 Aug; 134(4):323-331. PubMed ID: 32658524
[TBL] [Abstract][Full Text] [Related]
4. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.
Neill JC; Harte MK; Haddad PM; Lydall ES; Dwyer DM
Eur Neuropsychopharmacol; 2014 May; 24(5):822-35. PubMed ID: 24287012
[TBL] [Abstract][Full Text] [Related]
6. The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia.
Rajagopal L; Massey BW; Huang M; Oyamada Y; Meltzer HY
Curr Pharm Des; 2014; 20(31):5104-14. PubMed ID: 24345269
[TBL] [Abstract][Full Text] [Related]
7. Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine.
Reynolds GP; Neill JC
J Psychopharmacol; 2016 Nov; 30(11):1141-1144. PubMed ID: 27624147
[TBL] [Abstract][Full Text] [Related]
8. Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.
Grayson B; Barnes SA; Markou A; Piercy C; Podda G; Neill JC
Curr Top Behav Neurosci; 2016; 29():403-428. PubMed ID: 26510740
[TBL] [Abstract][Full Text] [Related]
9. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice.
Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S
Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia.
Chaki S; Shimazaki T; Karasawa J; Aoki T; Kaku A; Iijima M; Kambe D; Yamamoto S; Kawakita Y; Shibata T; Abe K; Okubo T; Sekiguchi Y; Okuyama S
Psychopharmacology (Berl); 2015 Aug; 232(15):2849-61. PubMed ID: 25869273
[TBL] [Abstract][Full Text] [Related]
11. Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction.
Rajagopal L; Soni D; Meltzer HY
Behav Brain Res; 2018 Sep; 350():31-43. PubMed ID: 29763637
[TBL] [Abstract][Full Text] [Related]
12. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N
Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189
[TBL] [Abstract][Full Text] [Related]
13. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.
Javitt DC; Zukin SR; Heresco-Levy U; Umbricht D
Schizophr Bull; 2012 Sep; 38(5):958-66. PubMed ID: 22987851
[TBL] [Abstract][Full Text] [Related]
14. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
[TBL] [Abstract][Full Text] [Related]
15. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism.
Braun I; Genius J; Grunze H; Bender A; Möller HJ; Rujescu D
Schizophr Res; 2007 Dec; 97(1-3):254-63. PubMed ID: 17601703
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis.
Gilmour G; Dix S; Fellini L; Gastambide F; Plath N; Steckler T; Talpos J; Tricklebank M
Neuropharmacology; 2012 Mar; 62(3):1401-12. PubMed ID: 21420987
[TBL] [Abstract][Full Text] [Related]
17. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
Lee M; Balla A; Sershen H; Sehatpour P; Lakatos P; Javitt DC
Neuropsychopharmacology; 2018 Feb; 43(3):571-582. PubMed ID: 28816240
[TBL] [Abstract][Full Text] [Related]
18. Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801.
Bygrave AM; Masiulis S; Nicholson E; Berkemann M; Barkus C; Sprengel R; Harrison PJ; Kullmann DM; Bannerman DM; Kätzel D
Transl Psychiatry; 2016 Apr; 6(4):e778. PubMed ID: 27070406
[TBL] [Abstract][Full Text] [Related]
19. PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia.
Pedersen CS; Sørensen DB; Parachikova AI; Plath N
Behav Brain Res; 2014 Oct; 273():63-72. PubMed ID: 25064467
[TBL] [Abstract][Full Text] [Related]
20. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
Brown JW; Rueter LE; Zhang M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
